HSBC taps Lazard to sell French retail business: source
HSBC Holdings has hired U.S. investment bank Lazard Ltd to sell its French retail business, a source close to the matter told Reuters, as part...
Intel buys software business from Canada’s Pivot Technology in 5G push
Intel Corp has agreed to purchase a software business from Toronto-based Pivot Technology Solutions Inc for $27 million, the U.S. chipmaker said on Tuesday....
Phase-out of Airbus, Boeing jets hits FACC’s operating profit
Plane parts maker FACC’s operating profit fell 6% in the second quarter as it produced fewer components for the Airbus A380 and Boeing 737NG jets...
Goldman profit falls short on weak underwriting, M&A advisory
Goldman Sachs Group Inc missed Wall Street’s estimates for quarterly profit on Tuesday as global economic worries dampened appetite for deals and share sales....
Wall Street opens higher on upbeat start to earnings
U.S. stocks opened higher on Tuesday, as strong earnings reports from JPMorgan Chase, UnitedHealth and Johnson & Johnson allayed concerns about the fallout from a...
Banks reap $1 billion from U.S. mortgage bond trading boom
Global banks earned $1 billion from trading government-backed U.S. mortgage securities in the first half of 2019, data shows, a fivefold increase on last year...
Wall Street headed higher on strong earnings start
Wall Street was set to open higher on Tuesday, as strong earnings reports from JPMorgan Chase, UnitedHealth and Johnson & Johnson allayed concerns about the...
BlackRock beats profit estimates as assets swell to nearly $7 trillion
BlackRock Inc , the world’s largest asset manager, exceeded analysts’ estimates for quarterly profit on Tuesday, as investors poured money into its fixed-income funds and...
JPMorgan beats profit estimates on strength in bond trading, underwriting
JPMorgan Chase & Co beat Wall Street estimates for quarterly profit by a wide margin on Tuesday, underpinned by strength in bond trading and underwriting....
Prescription drugs boost drives J&J forecasts higher, shares rise
Johnson & Johnson boosted its profit forecast for the year on Tuesday after posting better-than-expected quarterly earnings on stronger prescription sales of its psoriasis treatment...